Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, Peterfy C, Burlet N, Ethgen D, Montague T, Dabrowski C, Reginster J-Y
University of Liège, Department of Public Health, Epidemiology and Health Economics, CHU Sart-Tilman, 4000 Liège, Belgium.
Ann Rheum Dis. 2006 Aug;65(8):1050-4. doi: 10.1136/ard.2005.045914. Epub 2006 Jan 5.
To investigate the relation between biochemical markers of bone, cartilage, and synovial remodelling and the structural progression of knee osteoarthritis.
62 patients of both sexes with knee osteoarthritis were followed prospectively for one year. From magnetic resonance imaging (MRI), done at baseline and after one year, the volume and thickness of cartilage of the femur, the medial tibia, and the lateral tibia were assessed. A whole organ magnetic resonance imaging score (WORMS) of the knee was calculated for each patient at baseline and at the one year visits. This score consists in a validated, semiquantitative scoring system for whole organ assessment of the knee in osteoarthritis using MRI. Biochemical markers (serum hyaluronic acid, osteocalcin, cartilage glycoprotein 39 (YKL-40), cartilage oligomeric matrix protein (COMP), and C-telopeptide of type I collagen (CTX-I), and urine C-telopeptide of type II collagen (CTX-II)) were measured at baseline and after three months.
Baseline markers were not correlated with one year changes observed in cartilage volume and thickness. However, an increase in CTX-II after three months was significantly correlated with a one year decrease in mean thickness of medial tibial and lateral tibial cartilage. Patients in the highest quartile of three month changes in CTX-II experienced a mean loss of 0.07 (0.08) mm of their medial thickness, compared with a mean increase of 0.05 (0.19) mm for patients in the lowest quartile (p = 0.04) Multiple regression analysis showed that high baseline levels of hyaluronic acid are predictive of a worsening in WORMS (p = 0.004).
These results suggest that a single measurement of serum hyaluronic acid or short term changes in urine CTX-II could identify patients at greatest risk of progression of osteoarthritis.
研究骨、软骨和滑膜重塑的生化标志物与膝关节骨关节炎结构进展之间的关系。
对62例膝关节骨关节炎患者进行为期一年的前瞻性随访。根据基线期及一年后的磁共振成像(MRI)评估股骨、胫骨内侧和胫骨外侧软骨的体积和厚度。在基线期及一年随访时为每位患者计算膝关节的全器官磁共振成像评分(WORMS)。该评分采用一种经过验证的半定量评分系统,通过MRI对骨关节炎患者的膝关节进行全器官评估。在基线期及三个月后测量生化标志物(血清透明质酸、骨钙素、软骨糖蛋白39(YKL - 40)、软骨寡聚基质蛋白(COMP)、I型胶原C末端肽(CTX - I)以及尿II型胶原C末端肽(CTX - II))。
基线标志物与观察到的软骨体积和厚度的一年变化无相关性。然而,三个月后CTX - II的升高与胫骨内侧和外侧软骨平均厚度的一年减少显著相关。CTX - II三个月变化处于最高四分位数的患者,其内侧厚度平均损失0.07(0.08)mm,而处于最低四分位数的患者平均增加0.05(0.19)mm(p = 0.04)。多元回归分析表明,透明质酸的高基线水平可预测WORMS评分恶化(p = 0.004)。
这些结果表明,单次测量血清透明质酸或尿CTX - II的短期变化可识别骨关节炎进展风险最高的患者。